Javascript must be enabled to continue!
Splicing of designer exons informs a biophysical model for exon definition
View through CrossRef
Pre-mRNA molecules in humans contain mostly short internal exons flanked by longer introns. To explain the removal of such introns, exon recognition instead of intron recognition has been proposed. We studied this exon definition using designer exons (DEs) made up of three prototype modules of our own design: an exonic splicing enhancer (ESE), an exonic splicing silencer (ESS), and a Reference Sequence (R) predicted to be neither. Each DE was examined as the central exon in a three-exon minigene. DEs made of R modules showed a sharp size dependence, with exons shorter than 14 nt and longer than 174 nt splicing poorly. Changing the strengths of the splice sites improved longer exon splicing but worsened shorter exon splicing, effectively displacing the curve to the right. For the ESE we found, unexpectedly, that its enhancement efficiency was independent of its position within the exon. For the ESS we found a step-wise positional increase in its effects; it was most effective at the 3′ end of the exon. To apply these results quantitatively, we developed a biophysical model for exon definition of internal exons undergoing cotranscriptional splicing. This model features commitment to inclusion before the downstream exon is synthesized and competition between skipping and inclusion fates afterward. Collision of both exon ends to form an exon definition complex was incorporated to account for the effect of size; ESE/ESS effects were modeled on the basis of stabilization/destabilization. This model accurately predicted the outcome of independent experiments on more complex DEs that combined ESEs and ESSs.
Title: Splicing of designer exons informs a biophysical model for exon definition
Description:
Pre-mRNA molecules in humans contain mostly short internal exons flanked by longer introns.
To explain the removal of such introns, exon recognition instead of intron recognition has been proposed.
We studied this exon definition using designer exons (DEs) made up of three prototype modules of our own design: an exonic splicing enhancer (ESE), an exonic splicing silencer (ESS), and a Reference Sequence (R) predicted to be neither.
Each DE was examined as the central exon in a three-exon minigene.
DEs made of R modules showed a sharp size dependence, with exons shorter than 14 nt and longer than 174 nt splicing poorly.
Changing the strengths of the splice sites improved longer exon splicing but worsened shorter exon splicing, effectively displacing the curve to the right.
For the ESE we found, unexpectedly, that its enhancement efficiency was independent of its position within the exon.
For the ESS we found a step-wise positional increase in its effects; it was most effective at the 3′ end of the exon.
To apply these results quantitatively, we developed a biophysical model for exon definition of internal exons undergoing cotranscriptional splicing.
This model features commitment to inclusion before the downstream exon is synthesized and competition between skipping and inclusion fates afterward.
Collision of both exon ends to form an exon definition complex was incorporated to account for the effect of size; ESE/ESS effects were modeled on the basis of stabilization/destabilization.
This model accurately predicted the outcome of independent experiments on more complex DEs that combined ESEs and ESSs.
Related Results
Abstract 778: Dysregulation of alternative mRNA splicing by oncogenic KRAS in lung adenocarcinoma
Abstract 778: Dysregulation of alternative mRNA splicing by oncogenic KRAS in lung adenocarcinoma
Abstract
Alternative mRNA splicing is dysregulated in many cancers including lung adenocarcinoma. These aberrant splicing events can sometimes be explained by mutati...
Antisense oligonucleotides as a potential therapeutic strategy in hypertrophic cardiomyopathy caused by MYBPC3 variants
Antisense oligonucleotides as a potential therapeutic strategy in hypertrophic cardiomyopathy caused by MYBPC3 variants
Abstract
Funding Acknowledgements
Type of funding sources: Foundation. Main funding source(s): Sociedad Española de Cardiología
...
Abstract 1289: Crosstalk between methylation and alternative splicing in cancer
Abstract 1289: Crosstalk between methylation and alternative splicing in cancer
Abstract
Background: DNA methylation in promoter regions leads to transcriptional silencing, such as of tumor suppressor genes in cancer. However, the functions of D...
Exon Skipping as a Therapeutic for Neurofibromatosis Type I
Exon Skipping as a Therapeutic for Neurofibromatosis Type I
Abstract
We investigated the feasibility of utilizing an exon skipping approach as a genotype-dependent therapeutic for neurofibromatosis type 1 (NF1) by determining which ...
Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing
Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing
Understanding pre-mRNA splicing is crucial to accurately diagnosing and treating genetic diseases. However, mutations that alter splicing can exert highly diverse effects. Of all t...
Regulation of Alternative Splicing in B-Cell ALL By DYRK1A
Regulation of Alternative Splicing in B-Cell ALL By DYRK1A
DYRK1A, located in the Down syndrome critical region of chromosome 21, is a serine and threonine kinase that controls multiple cellular processes including apoptosis, cell cycle, t...
Abstract 1423: Integrative analysis predicts lncRNA regulating gene alternative splicing in breast cancer
Abstract 1423: Integrative analysis predicts lncRNA regulating gene alternative splicing in breast cancer
Abstract
Background: Non-coding region occupies 98% of the whole human genome and plays a
regulatory role for protein-coding genes. About 95% of the p...
Abstract 1513: Pan-cancer analysis of alternative splicing patterns and association to genomic aberrations
Abstract 1513: Pan-cancer analysis of alternative splicing patterns and association to genomic aberrations
Abstract
Alternative splicing of pre-messenger RNA is responsible for the diversity of transcriptome and proteome, with the majority of multi exon genes producing mu...

